1,884
Views
3
CrossRef citations to date
0
Altmetric
Research Papers

TNP and its analogs: Modulation of IP6K and CYP3A4 inhibition

, , ORCID Icon, , , , , ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 269-279 | Received 14 Jun 2021, Accepted 25 Oct 2021, Published online: 11 Dec 2021

References

  • Irvine RF, Schell MJ. Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2001;2:327–38.
  • Hatch AJ, York JD. Snapshot: inositol phosphates. Cell 2010;143:1030–e1031.
  • Chakraborty A, Kim S, Snyder SH. Inositol pyrophosphates as mammalian cell signals. Sci Signal 2011;4:re1.
  • Park SJ, Lee S, Park SE, Kim S. Inositol pyrophosphates as multifaceted metabolites in the regulation of mammalian signaling networks. Animal Cells and Systems 2018;22:1–6.
  • Lee S, Kim MG, Ahn H, Kim S. Inositol pyrophosphates: signaling molecules with pleiotropic actions in mammals. Molecules 2020;25:2208.
  • Wilson MS, Livermore TM, Saiardi A. Inositol pyrophosphates: between signalling and metabolism. Biochem J 2013;452:369–79.
  • Saiardi A, Erdjument-Bromage H, Snowman AM, et al. Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol 1999;9:1323–6.
  • Chakraborty A, Koldobskiy MA, Bello NT, et al. Inositol pyrophosphates inhibit akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 2010;143:897–910.
  • Ghosh S, Shukla D, Suman K, et al. Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels. Blood 2013;122:1478–86.
  • Lee TS, Lee JY, Kyung JW, et al. Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis. Proc Natl Acad Sci USA 2016;113:8314–9.
  • Park SJ, Park H, Kim MG, et al. Inositol pyrophosphate metabolism regulates presynaptic vesicle cycling at central synapses. iScience 2020;23:101000.
  • Illies C, Gromada J, Fiume R, et al. Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science 2007;318:1299–302.
  • Rao F, Xu J, Fu CL, et al. Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase b1. Proc Natl Acad Sci USA 2015;112:1773–8.
  • Fu C, Xu J, Li RJ, et al. Inositol hexakisphosphate kinase-3 regulates the morphology and synapse formation of cerebellar purkinje cells via spectrin/adducin. J Neurosci 2015;35:11056–67.
  • Moritoh Y, Oka M, Yasuhara Y, et al. Inositol hexakisphosphate kinase 3 regulates metabolism and lifespan in mice. Sci Rep 2016;6:32072.
  • Padmanabhan U, Dollins DE, Fridy PC, et al. Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates. J Biol Chem 2009;284:10571–82.
  • Ghoshal S, Zhu Q, Asteian A, et al. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway. Mol Metab 2016;5:903–17.
  • Zhu Q, Ghoshal S, Rodrigues A, et al. Adipocyte-specific deletion of IP6K1 reduces diet-induced obesity by enhancing ampk-mediated thermogenesis. J Clin Invest 2016;126:4273–88.
  • Chang YT, Choi G, Bae YS, et al. Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase. Chembiochem 2002;3:897–901.
  • Wundenberg T, Grabinski N, Lin H, Mayr GW. Discovery of InsP6-kinases as InsP6-dephosphorylating enzymes provides a new mechanism of cytosolic InsP6 degradation driven by the cellular atp/adp ratio. Biochem J 2014;462:173–84.
  • Lee KS, Kim SK. Direct and metabolism-dependent cytochrome p450 inhibition assays for evaluating drug-drug interactions. J Appl Toxicol 2013;33:100–8.
  • Sjogren E, Svanberg P, Kanebratt KP. Optimized experimental design for the estimation of enzyme kinetic parameters: an experimental evaluation. Drug Metab Dispos 2012;40:2273–9.
  • Kim D, Cryle MJ, De Voss JJ, Ortiz de Montellano PR. Functional expression and characterization of cytochrome p450 52a21 from candida albicans. Arch Biochem Biophys 2007;464:213–20.
  • Koldobskiy MA, Chakraborty A, Werner JK Jr, et al. P53-mediated apoptosis requires inositol hexakisphosphate kinase-2. Proc Natl Acad Sci USA 2010;107:20947–51.
  • Wang H, DeRose EF, London RE, Shears SB. IP6K structure and the molecular determinants of catalytic specificity in an inositol phosphate kinase family. Nat Commun 2014;5:4178.
  • Wormald M, Liao G, Kimos M, et al. Development of a homogenous high-throughput assay for inositol hexakisphosphate kinase 1 activity. PLoS One 2017;12:e0188852.
  • Azevedo C, Saiardi A. Extraction and analysis of soluble inositol polyphosphates from yeast. Nat Protoc 2006;1:2416–22.